Investing in electroCore, Inc. (ECOR)  ➔  Intrinsic value

Prev. close$0.96 
ModelValueUpside
Chepakovich$0.02-98%
Graham-Dodd$0.00-100%
Graham$0.00-100%
Previous Close$0.96  
Valuation MethodValuePotential 
Chepakovich Model$0.02-98%recalculate
Graham-Dodd$0.00-100%recalculate
Graham Formula$0.00-100%recalculate

Latest news

Company description

electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is headquartered in Basking Ridge, New Jersey.